Practice-changing research from Cedars-Sinai Cancer shows that a combination of androgen deprivation therapy—a commonly used hormone injection—plus pelvic lymph node radiation, kept nearly 90% of clinical trial patients’ prostate cancer at bay for five years. The findings were published in the peer-reviewed journal The Lancet.
![](https://sciencenewsnet.in/wp-content/uploads/2022/05/628fa566756e9_1920cedars-sinai-radiation-oncology-getty.jpg)